N-(Benzofuranazyl)-arylsulphonamides and their analogues useful as endothelin-receptor-antagonists

N-heterocyclyl-aryl-sulphonamides of formula (I) and their salts, excluding 4-(methyl, nitro or amino)-N-(2,1,3-benzothiadiazol-5-yl)-benzenesulphonamide are new: -A=B-C=D- is CH=CH-CH=CH in which 1 or 2 CH may be replaced by N; Ar = phenyl or naphthyl, opt. substd. by 1-3 of halo, Q, 2-6C alkenyl,...

Full description

Saved in:
Bibliographic Details
Main Authors OSSWALD, MATHIAS DR, WILM, CLAUDIA DR, MEDERSKI, WERNER DR, DORSCH, DIETER DR, CHRISTADLER, MARIA, SCHMITGES, CLAUS DR
Format Patent
LanguageEnglish
Published 30.07.1999
Edition6
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:N-heterocyclyl-aryl-sulphonamides of formula (I) and their salts, excluding 4-(methyl, nitro or amino)-N-(2,1,3-benzothiadiazol-5-yl)-benzenesulphonamide are new: -A=B-C=D- is CH=CH-CH=CH in which 1 or 2 CH may be replaced by N; Ar = phenyl or naphthyl, opt. substd. by 1-3 of halo, Q, 2-6C alkenyl, phenyl, phenoxy, NO2, NR4R5, NHCOR4, CF3, OCF3, CN, OR4, COOR4, (CH2)nCOOR4, (CH2)nNR4R5, NCO or NHCONR4R5; R1,R2 and R3 are absent or are H, halo, Q, CF3, NO2, NR4R5, CN, COOR4 or NHCOR4; R4 and R5 = H or Q, or together are CH2(CH2)nCH2; Q = 1-6C alkyl; X = O or S; halo = F, Cl, Br or iodo, n = 1-3.
Bibliography:Application Number: GR19990400984T